PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY was reported 13 times

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Histone Deacetylase Inhibitor [EPC] 1 0.0003
1 CD30-directed Immunoconjugate [EPC] 2 0.0002
2 Alkylating Drug [EPC] 3 0.0000
3 Corticosteroid [EPC] 6 0.0000
4 Thalidomide Analog [EPC] 2 0.0000
5 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000